This Article Full Text Full Text (PDF) All Versions of this Article: 27/2/170    most recent Final Manuscript Author Manuscript Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Macklon, N. S. Articles by Fauser, B. C. J. M. Search for Related Content PubMed PubMed Citation Articles by Macklon, N. S. Articles by Fauser, B. C. J. M.

The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization

Department of Reproductive Medicine and Gynecology (N.S.M., B.C.J.M.F.), University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands; Division of Reproductive Sciences (R.L.S.), Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon 97239-3098; and Department of Obstetrics and Gynecology (L.C.G.), Stanford University School of Medicine, Stanford, California 94305

Correspondence: Address all correspondence and requests for reprints to: N. S. Macklon, Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. E-mail: n.s.macklon{at}umcutrecht.nl

To allow selection of embryos for transfer after in vitro fertilization, ovarian stimulation is usually carried out with exogenous gonadotropins. To compensate for changes induced by stimulation, GnRH analog cotreatment, oral contraceptive pretreatment, late follicular phase human chorionic gonadotropin, and luteal phase progesterone supplementation are usually added. These approaches render ovarian stimulation complex and costly. The stimulation of multiple follicular development disrupts the physiology of follicular development, with consequences for the oocyte, embryo, and endometrium. In recent years, recombinant gonadotropin preparations have become available, and novel stimulation protocols with less detrimental effects have been developed. In this article, the scientific background to current approaches to ovarian stimulation for in vitro fertilization is reviewed. After a brief discussion of the relevant aspect of ovarian physiology, the development, application, and consequences of ovarian stimulation strategies are reviewed in detail.

This article has been cited by other articles:

				J. C. Boxmeer, R. P.M. Steegers-Theunissen, J. Lindemans, M. F. Wildhagen, E. Martini, E. A.P. Steegers, and N. S. Macklon Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation Hum. Reprod., November 1, 2008; 23(11): 2570 - 2576. [Abstract] [Full Text] [PDF]

				M.F.G. Verberg, M.J.C. Eijkemans, E.M.E.W. Heijnen, F.J. Broekmans, C. de Klerk, B.C.J.M. Fauser, and N.S. Macklon Why do couples drop-out from IVF treatment? A prospective cohort study Hum. Reprod., September 1, 2008; 23(9): 2050 - 2055. [Abstract] [Full Text] [PDF]

				N. S. Macklon, M. H. van der Gaast, A. Hamilton, B. C. J. M. Fauser, and L. C. Giudice The Impact of Ovarian Stimulation With Recombinant FSH in Combination With GnRH Antagonist on the Endometrial Transcriptome in the Window of Implantation Reproductive Sciences, April 1, 2008; 15(4): 357 - 365. [Abstract] [PDF]

				Y.-L. Lee, Y. Liu, P.-Y. Ng, K.-F. Lee, C.-L. Au, E. H.-Y. Ng, P.-C. Ho, and W. S.-B. Yeung Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation Hum. Reprod., April 1, 2008; 23(4): 894 - 903. [Abstract] [Full Text] [PDF]

				S. Polinder, E.M.E.W. Heijnen, N.S. Macklon, J.D.F. Habbema, B.J.C.M. Fauser, and M.J.C. Eijkemans Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint Hum. Reprod., February 1, 2008; 23(2): 316 - 323. [Abstract] [Full Text] [PDF]

				The ESHRE Capri Workshop Group Intracytoplasmic sperm injection (ICSI) in 2006: Evidence and Evolution Hum. Reprod. Update, November 1, 2007; 13(6): 515 - 526. [Abstract] [Full Text] [PDF]

				G. Nargund, B.C.J.M. Fauser, N.S. Macklon, W. Ombelet, K. Nygren, R. Frydman, and for the Rotterdam ISMAAR Consensus Group on Termin The ISMAAR proposal on terminology for ovarian stimulation for IVF Hum. Reprod., November 1, 2007; 22(11): 2801 - 2804. [Abstract] [Full Text] [PDF]

				K. J. McTavish, M. Jimenez, K. A. Walters, J. Spaliviero, N. P. Groome, A. P. Themmen, J. A. Visser, D. J. Handelsman, and C. M. Allan Rising Follicle-Stimulating Hormone Levels with Age Accelerate Female Reproductive Failure Endocrinology, September 1, 2007; 148(9): 4432 - 4439. [Abstract] [Full Text] [PDF]

				M. W. Szkudlinski Challenges and Opportunities of Trapping Ligands Mol. Pharmacol., August 1, 2007; 72(2): 231 - 234. [Abstract] [Full Text] [PDF]

				E. B. Baart, E. Martini, M. J. Eijkemans, D. Van Opstal, N. G.M. Beckers, A. Verhoeff, N. S. Macklon, and B. C.J.M. Fauser Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial Hum. Reprod., April 1, 2007; 22(4): 980 - 988. [Abstract] [Full Text] [PDF]